Hot flashes refractory to HRT and SSRI therapy but responsive to gabapentin therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15038336.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is a need for alternative therapies for hot flashes, as hormone replacement therapy (HRT) is associated with increased rates of breast cancer and heart disease, and some women fail to respond to HRT. A 32-year-old woman with surgically-induced menopause experienced 20-30 severe hot flashes per day and failed to respond to various formulations of HRT and selective serotonin reuptake inhibitor (SSRI) therapy for 17 years. She markedly responded to gabapentin therapy. Gabapentin, SSRIs, and estrogen may act at different cellular targets in the treatment of hot flashes.
Medical subject headings
- Acetates
- Amines
- Anticonvulsants
- Cyclohexanecarboxylic Acids
- Hormone Replacement Therapy
- Hot Flashes
- Selective Serotonin Reuptake Inhibitors
- gamma-Aminobutyric Acid